National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting, 7952 [05-2953]
Download as PDF
7952
Federal Register / Vol. 70, No. 31 / Wednesday, February 16, 2005 / Notices
Dated: February 8, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2956 Filed 2–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Hunter SNRP Type 2.
Date: February 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Excelsior Hotel, 45 West 81st Street,
New York, NY 10024.
Contact Person: Phillip F. Wiethorn,
Scientific Review Administrator, DHHS/NIH/
NINDS/DER/SRB, 6001 Executive Boulevard;
MSC 9529, Neuroscience Center; Room 3203,
Bethesda, MD 20892–9529, (301) 496–5388,
wiethorp@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: February 9, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2953 Filed 2–15–05; 8:45 am]
BILLING CODE 4140–01–M
VerDate jul<14>2003
12:44 Feb 15, 2005
Jkt 205001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Arthritis and
Musculoskeletal and Skin Diseases
Special Grants Review Committee,
February 28, 2005, 8 a.m. to February
28, 2005, 5 p.m., Bethesda Marriott,
5151 Pooks Hill Road, Bethesda, MD,
20814 which was published in the
Federal Register on January 26, 2005,
FR 70, 3721–3722.
The meeting date has changed to
February 27–28, 2005. The meeting will
begin the evening of February 27, 2005
from 7 p.m.–11 p.m. The morning of
February 28, 2005 the meeting will
begin at 7 a.m.–5 p.m. The meeting is
closed to the public.
Dated: February 9, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2954 Filed 2–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Statistical and Psychometric Applications for
Clinical Studies.
Date: February 24, 2005.
Time: 9 a.m. to 10:45 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Mark Czarnolewski, PhD,
Scientific Review Administrator, Division of
Extramural Activities, Neuroscience Center,
6001 Executive Blvd., Room 8122, MSC 9667,
Bethesda, MD 20892–9667, 301–345–4582,
mczarnol@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel,
Imaging and Mood Disorders II.
Date: March 3, 2005.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Peter J. Sheridan, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6142, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1513,
psherida@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: February 8, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2955 Filed 2–15–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, National
Institute of Mental Health.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Mental Health,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
E:\FR\FM\16FEN1.SGM
16FEN1
Agencies
[Federal Register Volume 70, Number 31 (Wednesday, February 16, 2005)]
[Notices]
[Page 7952]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2953]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Neurological Disorders
and Stroke Special Emphasis Panel, Hunter SNRP Type 2.
Date: February 24-25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Excelsior Hotel, 45 West 81st Street, New York, NY 10024.
Contact Person: Phillip F. Wiethorn, Scientific Review
Administrator, DHHS/NIH/NINDS/DER/SRB, 6001 Executive Boulevard; MSC
9529, Neuroscience Center; Room 3203, Bethesda, MD 20892-9529, (301)
496-5388, wiethorp@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: February 9, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-2953 Filed 2-15-05; 8:45 am]
BILLING CODE 4140-01-M